Menzaghi Claudia, Coco Angelo, Salvemini Lucia, Thompson Ryan, De Cosmo Salvatore, Doria Alessandro, Trischitta Vincenzo
Research Unit of Diabetology and Endocrinology, Scientific Institute "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo (FG) Italy.
J Clin Endocrinol Metab. 2006 Jul;91(7):2792-5. doi: 10.1210/jc.2005-2715. Epub 2006 May 2.
Serum levels of resistin are believed to modulate insulin resistance in humans.
The aim of this study was to investigate whether serum resistin levels are genetically controlled and whether this control is shared with other insulin resistance traits.
The study cohort included 264 nondiabetic probands, Caucasian from Italy, and their 473 adult family members. Phenotypic characterization included anthropometric variables, blood pressure, fasting glucose and insulin, lipid profile, and resistin levels. Genotypes were determined at position g.-420C-->G (rs1862513), IVS2+181G-->A (rs3745367), and GAT((n)) polymorphisms of the resistin (RETN) gene.
In the 264 unrelated probands, resistin levels were significantly (P < 0.01) correlated with adiposity, blood pressure, C-reactive protein, and the metabolic syndrome score. In a variance component analysis of the 264 probands and their 473 relatives, about 70% of the observed variation of serum resistin levels was heritable (P < 0.0001). A small, but significant (P = 0.004) proportion of this variance was explained by the G-->A variation at position IVS2+181 of the RETN gene. Significant genetic correlations (P < 0.05) were observed between resistin and body mass index (rho(g) = 0.30), waist circumference (rho(g) = 0.32), the insulin resistance index HOMA(IR) (rho(g) = 0.28), and the metabolic syndrome score (rho(g) = 0.35).
These data indicate that serum resistin is highly heritable and has some common genetic background with traits related to insulin resistance, reinforcing the hypothesis that this adipokine may play a pathogenic role in insulin resistance-related abnormalities, including type 2 diabetes and cardiovascular disease.
血清抵抗素水平被认为可调节人类的胰岛素抵抗。
本研究旨在调查血清抵抗素水平是否受基因控制,以及这种控制是否与其他胰岛素抵抗特征相关。
研究队列包括264名非糖尿病先证者(来自意大利的白种人)及其473名成年家庭成员。表型特征包括人体测量变量、血压、空腹血糖和胰岛素、血脂谱以及抵抗素水平。在抵抗素(RETN)基因的g.-420C→G(rs1862513)、IVS2+181G→A(rs3745367)和GAT((n))多态性位点测定基因型。
在264名无亲缘关系的先证者中,抵抗素水平与肥胖、血压、C反应蛋白和代谢综合征评分显著相关(P < 0.01)。在对264名先证者及其473名亲属的方差成分分析中,观察到的血清抵抗素水平变异约70%是可遗传的(P < 0.0001)。RETN基因IVS2+181位点的G→A变异解释了该变异的一小部分,但具有统计学意义(P = 0.004)。在抵抗素与体重指数(rho(g) = 0.30)、腰围(rho(g) = 0.32)、胰岛素抵抗指数HOMA(IR)(rho(g) = 0.28)和代谢综合征评分(rho(g) = 0.35)之间观察到显著的遗传相关性(P < 0.05)。
这些数据表明血清抵抗素具有高度遗传性,并且与胰岛素抵抗相关特征具有一些共同的遗传背景,这强化了这种脂肪因子可能在包括2型糖尿病和心血管疾病在内的胰岛素抵抗相关异常中起致病作用的假说。